COMMUNIQUÉS West-GlobeNewswire

Prominent Arkansas Health Plan Partners with Tabula Rasa Healthcare’s PrescribeWellness to Improve Quality & Performance Outcomes for its Members
11/04/2019
Pharmacies leverage Tabula Rasa HealthCare’s patient engagement tools and eCare platform to drive adherence among Arkansas member population MOORESTOWN, N.J. and IRVINE, Calif., April 11, 2019 (GLOBE NEWSWIRE) -- Tabula [...]
Translate Bio Appoints Robert Plenge, M.D., Ph.D., to its Board of Directors
11/04/2019
-- Appointment adds deep translational medicine expertise to support the Company’s mission of developing mRNA therapeutics for rare genetic diseases -- LEXINGTON, Mass., April 11, 2019 (GLOBE NEWSWIRE) -- Translate Bio [...]
Otonomy Initiates Phase 1/2 Clinical Trial of OTO-313 in Tinnitus
11/04/2019
Results expected in first half of 2020 SAN DIEGO, April 11, 2019 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, [...]
Albireo Announces FDA Clearance of IND to Commence Phase 2 Trial of Elobixibat for the Treatment of NAFLD/NASH
11/04/2019
– Initiation of Phase 2 clinical trial expected in Q2 2019 – – IBAT inhibition has potential to impact key markers of NASH – BOSTON, April 11, 2019 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical- [...]
Iterum Therapeutics Presents Data on Risks for Treatment Failure Associated with Uncomplicated Urinary Tract Infection and Activity of its Novel Antibiotic Sulopenem at ECCMID 2019
11/04/2019
The highest risk of treatment failure is seen in patients previously infected with a resistant pathogen. Sulopenem has in vitro activity against isolates of Neisseria gonorrhoeae non-susceptible to quinolones, [...]
Aleafia Health Increases Strategic Investment in Australian LP CannaPacific
11/04/2019
CannaPacific Also Closes its Acquisition of 108,000 sq. ft. Greenhouse for Cannabis Cultivation Australian LP is Federally Licensed to Cultivate and Research Cannabis TORONTO and NEWCASTLE, New South Wales, April 11, [...]
Assembly Biosciences Presents Data Highlighting Next-Generation HBV Core Protein Inhibitors at EASL 2019
11/04/2019
Phase 1a study of ABI-H2158 demonstrated safety, tolerability and achievement of target liver concentrations ABI-H3733 demonstrated enhanced potency in preclinical studies HBV cccDNA shown to have a limited half-life, [...]
Zealand Pharma to attend ABG Sundal Collier Small & Mid Cap Seminar
11/04/2019
Press release – No. 08 / 2019 Zealand Pharma to attend ABG Sundal Collier Small & Mid Cap Seminar Copenhagen, April 11, 2019 – Adam Steensberg, Interim Chief Executive Officer, will attend the ABG Sundal Collier [...]
Trillium Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
11/04/2019
TORONTO, April 11, 2019 (GLOBE NEWSWIRE) -- Trillium Therapeutics Inc. (Nasdaq/TSX: TRIL) , a clinical-stage immuno-oncology company developing innovative therapies for the treatment of cancer, today announced that it [...]
Scholar Rock Announces Appointment of Lisa Amaya Price as Senior Vice President, Human Resources
11/04/2019
Experienced biopharmaceutical HR executive expands leadership team and supports growth as company advances portfolio of product candidates CAMBRIDGE, Mass., April 11, 2019 (GLOBE NEWSWIRE) -- Scholar Rock Holding [...]
Revive Therapeutics Announces Collaboration and Royalty Agreement With Richmond Cannabis Co.
11/04/2019
TORONTO, April 11, 2019 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (" Revive " or the " Company ") (TSX VENTURE: RVV) (OTCQB: RVVTF), a specialty cannabis company focused on the research, development and [...]
FSD Pharma Explores Insurance Coverage for Medical Cannabis in Canada -- CFN Media
11/04/2019
SEATTLE, April 11, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry announces publication of an [...]
Nabriva Therapeutics to Present Data at ECCMID Demonstrating Potential of Lefamulin for Patients with Community-acquired Bacterial Pneumonia (CABP) and CONTEPO™ (fosfomycin for injection) to Treat Complicated Urinary Tract Infections (cUTIs)
11/04/2019
New data continue to support lefamulin and CONTEPO as potential first-in-class antibiotics in the United States that target the most common causative pathogens of CABP and cUTI, including multi-drug resistant (MDR) [...]
Tetra Bio-Pharma and Ovensa Will Engage in a Collaboration to Tackle Brain Cancer
11/04/2019
Proprietary nanomedicine platform for targeted delivery of cannabinoids to brain tumors including glioblastoma multiforme OTTAWA, April 11, 2019 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc. (" Tetra " or the " Company ") ( [...]
Tetra Bio-Pharma et Ovensa s’engagent à collaborer pour lutter contre le cancer du cerveau
11/04/2019
Une plateforme de nanomédicine exclusive pour la livraison ciblée de cannabinoïdes aux tumeurs cérébrales, y compris le glioblastome multiforme OTTAWA, 11 avr. 2019 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc. (« Tetra [...]
Correction: Oncology Venture today publishes a supplement to the prospectus published April 5, 2019 - without MAR plate
11/04/2019
Press release Correction: MAR plate removed from this press release Oncology Venture today publishes a supplement to the prospectus published April 5, 2019 Oncology Venture A/S hereby announces a supplement to the [...]
Philips and Vietnamese Hong Duc General Hospital sign multi-year strategic partnership agreement
11/04/2019
11 April 2019 Philips to provide turnkey hospital solution to newly-built Hong Duc General Hospital II, including the latest medical imaging and healthcare IT solutions as well as design, consulting and financing [...]
Acetium® lozenge for smoking intervention will be available in Thailand during the year 2019
11/04/2019
Press release 11th April 2019 at 09.30 local time (EEST) Biohit Oyj and Precision Health Co., Ltd have signed an agreement for the distribution of the Acetium lozenge in Thailand. The effectiveness of Acetium® lozenge [...]
Curetis Publishes Full-Year 2018 Financial Results and Updated Guidance for 2019
11/04/2019
- Launched Unyvero System and Unyvero LRT Cartridge in the U.S. - Increased revenues to EUR 1.4 million in 2018 - Raised EUR 19.5 million additional funding - Revised focus and strategy Amsterdam, the Netherlands, and [...]

Pages